A phase of a clinical trial in which both doctors and patients know what treatment patients are getting. Open-label phases usually happen after the placebo-controlled portion of the clinical trial is over, and are meant to test the long-term effects of a treatment.

CreativeMinds WordPress Plugin CM Tooltip Glossary